Background: To evaluate whether salivary lead can be used as a surrogate for blood lead, and if so, over what concentration range. Methodology: Three saliva devices were evaluated and one chosen to undertake this project. Paired saliva and blood samples were collected from 89 UK lead workers. Lead concentrations were determined using ICP-MS. In addition, haemoglobin and ZPP levels were determined in the blood samples and albumin was determined in the saliva samples to investigate standardisation using protein adjustments. Results: The chosen saliva device gave low but consistent recoveries for lead in saliva and the blank levels were low.
Introduction
Human biomonitoring of environmental exposures is becoming increasingly important for health protection. Biomonitoring involves assessment of biomarkers of exposure, uptake and effect in human tissue: historically this has mostly been applied to occupational settings. Such is the case for inorganic lead where lead workers are routinely monitored for exposure by determining lead concentrations in blood samples. Exposures to lead can occur by two main routes -ingestion and inhalation, and to a lesser extent dermal absorption; these exposures then contribute to an internal concentration or body burden of lead.
Blood is the most common biological sample used to assess both occupational and environmental exposures to inorganic lead. However, the invasive and traumatic nature of blood sampling from children and the elderly makes this matrix less acceptable for these age groups. Furthermore, the need for trained phlebotomists and many other factors including sample transport/storage and ethical approval issues make blood far from ideal for human biomonitoring, particularly in large general population surveys. Urinary biomarkers are less appropriate for assessing inorganic lead exposure because the uptake of lead is associated with red blood cells; urine mostly reflects organic lead exposure. Thus, there is a need to develop and validate non-invasive techniques for human biomonitoring that reflect exposure to inorganic lead.
There has been an increasing interest since the mid-1950s in the potential for using measurements in oral fluids for diagnosis and toxicological reasons. This has been largely driven by the non-invasive nature of the sample, the ability to undertake multiple sampling and a firmer understanding of the mechanisms of how substances are expressed in oral fluid. Oral fluid (OF) is the generic term applied to the fluid obtained from the mouth. It has also been termed 'mixed saliva' and is produced at a rate of about 40-70 ml/hour averaged over a day [1] . There is a range of devices, based on an absorptive swab, that are designed to collect (and indicate) a defined minimum volume of saliva/oral fluid; many of these have been developed for use in drugs of abuse testing. Some of these devices 'elute' the saliva sample into a buffer whereas others squeeze the saliva directly into a sample tube. These devices should mean that more consistent and comparable samples can be collected (both within a study and between researchers). One of the issues of saliva sampling in the past has been the different collection techniques used and the inconsistent and varied use of stimulants, in order to increase saliva flow.
Even though the use of lead has been restricted since the 1970's, for example, with the introduction of lead free drinking water pipes and lead free petrol which has resulted in a reduction in blood lead levels there are still concerns that lead exposure is a contributor to intellectual impairment in children and a contributing factor for other diseases [2] . Childhood lead exposure has long been of concern with respect to affecting IQ and other mental capacity. Studies have shown that impairment occurs even below the previously considered 'safe' target level of 10 µg/dl and that low environmental lead exposure may affect mortality [3] [4] . This absence of an identified blood lead level without deleterious effects has led CDC to remove their 'level of concern' value of 10 µg/dl and instead recommend that children with a blood lead level in excess of 5 µg/dl should receive on-going monitoring and interventions to reduce their lead exposure [5] . Thus, there is a need to monitor the exposure levels in the general population and, in the light of the discussion above; a non-invasive technique such as salivary analysis would be invaluable.
Salivary lead measurements have been reported in the literature and compared with blood lead levels with varying results. Some authors have claimed that salivary lead is not a suitable marker of lead exposure [6] [7] , whereas others have found significant correlation between saliva and blood lead levels [8] . These previous studies have used different collection techniques (both stimulated and un-stimulated) and there is no evidence that authors looked at the protein content of the collected samples, which may be a way of standardising samples (much as creatinine concentration is used for urine dilution).
The aim of this work was to assess the utility of saliva samples for determining lead exposure. Firstly, three saliva devices were evaluated for their suitability and the most suitable device was chosen for the main study. Such devices are now widely employed in drugs of abuse testing and it was felt that using a device (rather than free collection) would provide a convenient and standardised sample. Then blood and saliva samples were collected from workers in the UK being routinely monitored for exposure to lead in their workplace. The concomitant collection of saliva and blood allowed comparison between the two matrices. The advantage of obtaining samples from a variety of different workplaces is that the workers exhibited a range of lead concentrations, allowing a more comprehensive assessment of correlation. Concentrations of lead in blood and saliva samples were determined, and to investigate the possibility of protein adjustments in the samples haemoglobin levels were also determined in blood samples and albumin levels were determined in saliva samples.
Materials and methods

Sample Collection
The study protocol was reviewed by the Chair of Berkshire Research Ethics Committee. All participants provided informed consent, in accordance with HSG 167 [9] .
Occupational health providers currently using HSL for routine biomonitoring of lead were contacted as to whether they would be willing to recruit workers to participate in the study. If they were agreeable, volunteer information and consent forms were sent along with appropriate sampling kits. Workers were asked whether they would volunteer to provide a saliva sample at the same time as their next routine blood sample. The paired samples were returned to the laboratory for analysis. The blood samples were analysed and reported in the usual way. Saliva samples were anonymised before analysis and paired with the anonymised blood results.
Study participants
Workers agreeing to take part in the study (n=89) provided both a blood sample and a saliva sample on the same day. The workers consisted of 85 males, 1 female and 3 of unspecified gender. The age range of the workers was 17.3-62.5 years with a mean and standard deviation of 36.9 ± 11.5 years. Within the group of workers there were 45 nonsmokers, 30 smokers and 14 of unknown smoking status.
Saliva Collection Devices
Three saliva collection devices were evaluated in this study. 1 1. The Sarstedt Salivette consists of a swab in the upper part of a tube, which is placed in the mouth or under the tongue until it is sufficiently saturated and it is no longer possible to prevent swallowing saliva. Manufacturer instructions estimate this will take about 45 seconds. Once the swab is saturated it is returned to the top chamber of the tube and capped. The tube is centrifuged and the saliva in the swab is driven into the bottom compartment of the tube, leaving a reservoir of saliva to be analysed.
2. The Cozart Oral Fluid Collection Kit consists of a tube containing a buffer solution and an individually wrapped bud on a stick swab. The bud is placed in the mouth and the gums, tongue and cheek are swabbed. The swab is held inside the mouth until the indicator on the stick turns blue. It is then placed into a tube containing buffer and the tube capped. The tube has an insert in the bottom of the tube that fixes the swab in place and allows the sample to be decanted out easily for analysis.
3. The Quantisal Saliva Collection Device works in the same way as the Cozart device apart from the swab is in the form of a paddle rather than a bud. The paddle is placed inside the mouth and left until the indictor turns blue. The swab is then placed into the buffer-containing tube. The cap fixes the swab and allows the swab to be removed to allow decanting of the sample.
Only the first device collects pure saliva, the other two are designed to elute the saliva into a buffer -this dilutes the sample but ensures a more consistent volume collection. Because of commercial sensitivities, the formulations of the buffers used in these devices are not available.
Analytical Method
Blood Samples
Blood samples were analysed for lead content using ICP-MS (Thermo X Series 2, Hemel Hempstead, UK). Blood samples were diluted 1 in 40 with an alkaline diluent (1 g/l EDTA and 0.1% v/v Triton X-100 (Fisher Scientific, Loughborough, UK), 1% v/v ammonia (Romil Ltd, Cambridge UK), 80 µg/l platinum (VWR Standards, Lutterworth, Leicestershire) as an internal standard) and analysed in normal mode ICP-MS using a miramist nebuliser. This method is ISO17025 accredited and there is extensive external quality assurance (monthly NEQAS (www.ukneqas.org.uk), annual G-EQUAS (www.gequas.de) schemes). Certified reference materials, Lyphochek Whole Blood Controls (Bio-Rad Laboratories Ltd, Hemel Hempstead, UK,), were analysed with each analysis and all values were within the defined ranges (BR1: 9.0 -13.5 µg/dl, BR2: 22.6 -33.9 µg/dl, BR3 -38.1 -57.2 µg/dl). Blood samples were also analysed for haemoglobin (Hb) and zinc protoporphyrin (ZPP), as early biological effect markers. All ZPP measurements were carried out using an Aviv 206 haematofluorimeter and the recommended Aviv quality control samples (Aviv Biomedical, New Jersey USA) were analysed at the start and at the end of each analysis. All haemoglobin analysis was carried out using a Cobas Mira analyser (Roche, Basel, Switzerland). Haemoglobin accuracy was ensured using internal quality control samples and participation in the external quality assessment scheme RIQAS (www. riqasconnect.randox.com).
Saliva Samples
Selection of sample collection device
The three devices were tested for the recovery of lead using blank and spiked saliva solutions (blank saliva was obtained from Innovative Research, Michigan, USA). Each device was placed in 1 or 2 ml of blank saliva, 1 or 2 ml of spiked saliva at a concentration of 1 µg/l lead and 1 or 2 ml of spiked saliva at a concentration of 10 µg/l lead. Each of these conditions was tested using two devices and the mean result reported.
The Sarstedt salivette was left for 2 minutes to soak up the saliva. Once complete, the swab was returned to its pot and centrifuged for 10 minutes at 3000 rpm. The swabs from both the Quantisal and Cozart devices were left in the saliva until the indicators turned blue (as per manufacturer instructions, approx. 1 minute). Once colour change occurred, the swabs were placed into their tubes containing buffer, capped and left to mix on the roller mixer for 20 minutes. The volume of buffer was 2 ml for the Cozart device and 2.8 ml for the Quantisal device -these volumes were accounted for in the recoveries.
Saliva Sample Preparation
Samples were stored frozen as intact sampling devices (i.e. with the cotton swab immersed in the collection buffer) until analysis. Prior to analysis samples were brought to room temperature and mixed on a roller mixer for 15 minutes before being centrifuged upside down for 15 minutes at 3000 rpm. Being careful not to get the buffer back onto the swab the tube was opened and the contents transferred to a collection vessel. Centrifuging the swab upside down was necessary to maximise the recovery and reproducibility of lead from the collection devices. This procedure caused the volume indicator dye to be released into the sample but this did not interfere with the analysis.
Saliva Analysis
Saliva samples were also analysed by ICP-MS. All samples were diluted 1 in 10 with an acid diluent (consisting of 0.2 g/l EDTA (Fisher Scientific, Loughborough, UK) and 10 µg/l platinum (VWR Standards, Lutterworth, Leicestershire) as an internal standard, in 1% v/v nitric acid (Romil Ltd, Cambridge UK) and analysed in duplicate. Standards were prepared over the range 1 to 50 µg/l in water. An internal quality control (QC) material was prepared by spiking blank saliva (10 µg/l Pb). Aliquots were analysed in each analysis.
Saliva albumin analysis
Albumin was measured on an automated biochemical analyser (Pentra 400, Horiba ABX, France) using a standard reagent kit supplied by ABX using the same methodology as for urine samples. Internal quality control samples were analysed with each batch and the laboratory participates in the external quality assessment scheme RIQAS for urine sample analysis.
Statistical methods for the comparison of the blood and saliva methods
The distributions of the blood lead and saliva lead data were examined. Normality was tested using the ShapiroWilk W test; as a consequence, the statistical analysis was undertaken on the log 10 -transformed salivary and blood lead variables. The relationship between the blood and saliva data was investigated using correlation and regression analysis. Simple linear regression was used to identify which factors were important in predicting salivary lead levels. As a result of the varying volumes of saliva collected the possibility of protein-adjustment was investigated by correcting the salivary lead concentration for the salivary albumin concentration to see if this might act as a dilution compensation factor (as creatinine can be for urine samples). Lead is known to be bound to erythrocytes; it is therefore possible that lead in saliva may be bound to albumin. Blood lead results (corrected for haemoglobin content) were consequently compared to salivary lead results corrected for albumin content. It should be noted that acute lead exposure will cause reduced haemoglobin levels and so this protein-adjustment ratio for blood is not an independent variable (although all the haemoglobin values in the samples tested fell within normal ranges). It should also be noted that both females and children are likely to have lower haemoglobin levels and therefore bias could arise in studies using these cohorts. Agreement between salivary lead and blood lead values was examined by means of a Bland-Altman plot and Deming regression. The Bland-Altman plot shows the difference between the two measures on the vertical axis, and the average of the two measures on the horizontal axis. The 95% limits of agreement were calculated on the log 10 scale, back transformed using the methods described by Euser and colleagues [10] , and included in the BlandAltman plot on the original scale. Deming regression is an errors-in-variables model that assumes errors in both the dependent and the independent variable. It can be used to assess equality in the two measures of lead. The analyses were undertaken for all the samples and for the subset of samples which had ZPP concentrations <3.5μg/g haemoglobin.
Results
Suitable Saliva Collection Device
Recoveries of lead from the tested collection devices are shown in Figure 1 . The Sarstedt salivette device showed that better results were attained with the 2 ml of saliva compared with the 1 ml of saliva; in fact, it was possible to see that 1 ml of saliva had not saturated the entire swab. The recoveries of the concentrations were around 30% with a marked lower recovery around 7% for the 1 ml of 10 µg/l spiked saliva. This device is designed to work by being saturated (as confirmed by the data above). Unlike the other devices, there was no objective indicator that sufficient volume has been collected (e.g. a colour change indicator). It was clear that highly variable sample volumes are probable using this device.
The Quantisal saliva-sampling device showed the best recoveries typically 40-65%. However, there was an issue with blank samples giving inconsistent, occasionally high results and having to be discounted from the analysis. For this reason, the Quantisal saliva-sampling device was ruled out as a suitable device for lead analysis.
The Cozart saliva-sampling device only gave recoveries of around 30-35% for both the 1 µg/l and 10 µg/l spiked saliva solutions but this was a consistent recovery and there were no issues with blank results. The buffer was shown to have low lead levels. Overall, there was a 6% variation in recovery across both saliva volumes (1 and 2 ml) and both spiked concentrations (1 µg/l and 10 µg/l).
The saliva-sampling device of choice for lead analysis therefore was the Cozart sampling device.
Analytical Performance
The certified reference materials were all within range for the blood lead analysis (CV 3.4%, n=17). The limit of detection for the blood lead analysis was 0.2 µg/dl.
The lead content in blank saliva (pooled from multiple volunteers, commercially sourced from Innovative Research, USA) ranged from 0.1 to 0.8 µg/l (mean =0.26 µg/l, n=30). The nominal 10 µg/l saliva internal QC material showed a mean result of 12.1 µg/l with a coefficient of variation of 11.2% (n=30). The limit of detection in saliva was calculated to be 0.02 µg/l. All samples from workers were above the limit of detection.
Saliva and blood lead results
Paired blood and saliva samples (n=89) were collected from workers being assessed for lead exposure at work under the Control of Lead at Work Regulations [10] . Summary statistics of the saliva and blood lead data are shown in Table 1 . Comparison of the arithmetic and geometric means and the medians suggested that the blood lead data were approximately normally distributed but Shapiro-Wilk W test indicated that both blood lead and the salivary lead data were not normally distributed (p < 0.001). The table shows a broad range of blood lead results (from 2 to 54 µg/dl) with all results below the UK current suspension limit of 60 µg/dl. The majority (75%) of blood lead concentrations were at least ten-fold higher than the salivary lead concentrations. In addition, 31 samples had a blood lead level of less than or equal to 10 µg/dl and so are of some relevance to environmental exposures. The blood lead and salivary lead data were not normally distributed and so the data was log 10 -transformed for the correlation analysis. The correlation between log 10 salivary lead and log 10 blood lead was 0.69 (p < 0.001), between log 10 salivary lead and log 10 ZPP was 0.224 (p = 0.036), and between log 10 salivary lead and haemoglobin was -0.144 (p = 0.201). The regression analysis of blood lead on salivary lead was undertaken using the variables on their original scale and on the log 10 -transformed scale. Comparing the Akaike Information Criterion (AIC) for the final models indicated that the log 10 -transformed model (AIC = 116) was substantially better than the equivalent model using the data on their original scale (AIC = 870). Consequently, regression analysis for log 10 -transformed data was used to investigate potential predictors of salivary lead concentration. The influence of protein-adjustment was also considered -blood lead levels were adjusted for haemoglobin content and the salivary lead levels were adjusted for albumin content. The data were log-transformed. These protein-adjustments did not improve the correlation between blood and saliva. Uncorrected salivary lead concentration (µg/l) is therefore the preferred means of comparing saliva results with blood lead.
In comparing the differences within the workers, no association was observed between either blood or saliva lead concentrations with smoking status. In the regression model of log 10 salivary lead on log 10 blood lead, the term for smoking was not statistically significant (p = 0.738). Similarly, age was not seen to be statistically significant in this regression model (p = 0.162). The correlation between the log 10 -transformed values of blood lead and salivary lead, adjusted for smoking status was 0.65, and adjusted for age was 0.69.
Agreement between the two measures (blood and saliva) was assessed using the Bland-Altman plot (Figure 2) . Figure 2 shows the observed differences between salivary lead and blood lead plotted against the corresponding mean of the salivary lead and blood lead values. Plotted on the original scale, it is clear that the differences tend to increase as the mean increases. Limits of agreement calculated on this scale will be inappropriate because the range of differences depends on the average value of the two measures. The 95% limits of agreement calculated on the log 10 scale were back transformed to the original scale, and included in Figure 2 , in order to enable interpretation on the original scale. The observed differences mainly lie within the 95% limits of agreement. These limits increase as a multiple (1.55) of the mean of salivary lead and blood lead values. The Deming regression of log 10 salivary lead on log 10 blood lead confirmed the presence of the systematic difference in salivary lead and blood lead concentrations observed in the Bland-Altman plot. The regression coefficient for log 10 blood lead was 1.65 (95% CI (1.30, 2.00); p-value < 0.001) indicating that there was a strong linear relationship between log 10 salivary lead and log 10 blood lead concentration and that there is a proportional difference between the two measurements. The results of the Deming regression are presented on the original scale in Figure 3 . The observed values are widely scattered around the line of best fit. As in the BlandAltman plot, the 95% confidence interval for the predicted mean increases with the blood lead value.
Because of the observation that the differences between the methods seem to increase with increasing exposure, a sub-set of the samples was also examined where ZPP levels were less than 3.5 µg/g haemoglobin. This cut-off was chosen as an indication that recent lead exposure had not been sufficient to cause any biochemical effects in the subjects. When looking at this reduced sample set (Figure 4, n=32) , the fit of the Deming regression improves (1.80 (95% CI 1.35-2.24); p < 0.001).
The Deming regression can be used to estimate lead salivary "cut-offs" that if exceeded might indicate increased lead exposure and the need for health surveillance (in an occupational setting) or to identify groups or individuals with higher-than-expected environmental exposure. The current UK workplace regulations [11] deem that a blood lead level of >20 µg/dl for women of reproductive capacity or >35 µg/dl for all other workers indicates 'significant' lead exposure, requiring health surveillance. Using the upper 95% confidence interval, the lowest concentration of salivary lead that would indicate a mean blood concentration >20μg/dl and >35μg/dl are 17.1 μg/l and 47.2 μg/l respectively.
Discussion
Although all the samples in this study are from UK lead workers, the blood lead levels observed in this study range from environmental levels to significant workplace exposures (2-54 µg/dl). The mean blood lead (20 µg/dl) was below all UK biological monitoring guidance levels. The blood to saliva ratio was approximately 10:1. This ratio compares with other published studies.
This study has shown that there is a reasonable correlation between blood and salivary levels in occupationally exposed workers, despite the difference in elimination kinetics (blood lead levels reflect exposure over several months, reflecting the lifespan of erythrocytes, whereas saliva has an estimated half-life of 5-7 days [12] ). This may indicate that the lead body burden of workers who undergo routine biological monitoring are generally at steady state. However, the dataset exhibited a lot of variability, perhaps reflecting the different kinetics of the two biomarkers and a range of exposure histories. Similar correlations in the occupational field have been reported previously. P'an compared blood and saliva in 266 males, split into four exposure categories including 88 controls [8] . Saliva was collected by free dribbling after citric acid stimulation and the study reported a good correlation (r=0.80) between log-transformed blood and salivary lead levels. Exposures were higher than those generally currently reported -even the control group mean blood lead level was 18 µg/dl, with the highest exposure group showing a mean blood level of 81.8 µg/dl. A tendency for salivary lead levels to rise dramatically when blood lead levels exceeded 50 µg/dl (the current UK action level) was also observed. P'an demonstrated that a salivary lead level of 80 µg/l had 95% sensitivity and 92% specificity of detecting subjects with a blood lead level of greater than 40 µg/dl. Our study showed a similar level of correlation between log-transformed blood and salivary lead results and using the Deming regression, a salivary lead level of 70 µg/l would be predicted from a blood lead level of 40 µg/dl, showing a reasonable agreement with P'an at this exposure. P'an observed a dramatic rise in salivary lead levels when blood lead exceeds 50 µg/l. Although very few of our data exceeded this value, the Bland-Altman plot indicated an increase in disparity between blood and saliva with increased exposure levels. P'an also reported a reverse in the blood to saliva ratio, which was 3:1 in the control group and then 1:3 in the highest exposed group. In a similar occupational study to our study Koh et al in 2003 concluded that blood lead levels between 10-50 µg/dl were not appropriate for determining by saliva because they found only 1:35 blood: saliva ratio [13] . However, the findings in our study show that there is a good correlation at this concentration range.
Lead saliva is generally considered to represent the free lead fraction in blood although the relationship is far from simple [14] . Whilst the largest proportion of absorbed lead in blood is known to be bound to erythrocytes (mainly associated with haemoglobin), there is also an equilibrium with plasma. It has been suggested that salivary lead arises from the diffusible fraction of plasma lead [12] . Blood lead and plasma lead levels have been shown to be correlated although there are gender and possibly age differences [15] . The shorter half-life of lead in saliva and its faster response to re-exposure [12] , makes salivary lead potentially a better indicator of recent exposure and more useful for determining the need for interventions or improvements in exposure control, particularly during work such as demolition or renovation where the job may be complete before blood lead levels have shown a response.
There have been a number of studies looking at salivary lead to study environmental exposures but their results vary widely [6, 7, 14, 16] . Nriagu conducted a large study (n=970, 95% female) looking at blood and salivary lead levels in an American urban population [14] . Saliva was collected by dribbling into a tube without stimulation. Blood lead levels were typical of a western industrialised population ranging from <0.15 µg/dl to over 20 µg/dl with an average of 2.7 µg/dl (±0.1 µg/dl). The corresponding mean (± standard deviation) salivary lead level was 2.4 ± 0.13 µg/l. The ratio of the means (~10:1 blood: saliva) is broadly similar to our study despite the much greater variation in our population (due to occupational exposure). Nriagu found a weak but statistically significant correlation between blood and salivary lead levels (Pearson correlation 0.16) and this correlation increased with exposure when results were grouped into blood lead 'bands' [14] . These findings are similar to those in a recent study in Thailand that compared lead saliva and blood levels in 120 paired samples from children living near a contaminated ship yard area [16] . Saliva was collected by free dribbling and a detection limit of 1 µg/l was reported. The results showed that blood lead was weakly correlated to saliva lead levels with a mean blood lead level of 9.49 ± 3.78 µg/dl and a mean saliva level of 2.26 ± 3.67 µg/dl and an eight-fold difference between the blood and saliva lead levels. This ratio between the saliva and blood levels compares with that observed in this study.
A German group looked at lead exposure in 245 children in 2002 [6] . Saliva was collected by free dribbling without stimulation. Their reported detection limit for salivary lead was 1.5 µg/l and 89% of the saliva samples were below the detection limit for lead. The authors concluded that salivary lead was therefore not suitable for assessing environmental lead exposure of children. However the analytical method used cannot be considered fit for purpose -using a detection limit of 1.5 µg/l, 45% of our 'environmental' saliva samples (blood lead less than 10 µg/dl) would also be 'none detected' for lead. Much lower detection limits than reported by Wilhelm are needed if looking at saliva samples for environmental exposures. Our study detected lead levels in all saliva samples (detection limit 0.024 µg/l).
More recently, publications from Costa de Almeida et al have reported conflicting conclusions for the salivary lead correlations with environmental lead contamination (as measured by lead in enamel) in children [17] [18] . Early research from de Almeida group showed a clear relationship between salivary lead and environmental lead exposure but their further studies looking at correlations between biomarkers have not demonstrated significant correlation between blood and salivary lead.
Although our study did not use an 'environmentally exposed' population, improvement in the Deming regression when looking at samples with a ZPP level of <3.5 µg/g haemoglobin may indicate that saliva may be better correlated at environmental levels where exposures are generally more consistent and chronic and overt biochemical effects (such as raised ZPP level) are less likely to be observed.
Our study has shown that the salivary lead measurements may have value in being used as a screening technique to determine whether lead exposures are increasing (for example, during demolition or renovation work, avoiding multiple blood samples) or to do an initial assessment of whether the lead exposures are 'significant' in terms of requiring health surveillance under law.
Conclusion
Much of the conflicting data in the literature may be explained by different collection techniques, different exposed populations and analytical methods with high limits of detection. This study has demonstrated that salivary lead measurement is feasible and correlated with blood lead levels within an occupationally exposed cohort. Results from this study also showed that the correlation between blood lead and saliva lead was not improved when a protein adjustment was undertaken, i.e. that blood lead was corrected by the haemoglobin concentration and saliva lead was corrected by the albumin concentration. These findings could suggest that lead in saliva is not bound to the albumin content.
Whilst we have presented a standardised method of collection and a very sensitive detection method suitable for use in environmental surveys, a further survey of genuinely non-occupationally exposed people is required to investigate the use of salivary lead measurements at environmental levels. It would also be advantageous to compare multiple saliva samples for lead from individuals to ascertain the variation in lead levels that may occur.
